Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (101-110 of 470) with videos related to

Pageof 47
Sort By:
Neuroscience and Biobehavioral Reviews|February 2, 2013
Interleukin-17 in post-stroke neurodegenerationWalter Swardfager, Daniel A Winer, Nathan Herrmann, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 15, 2005
Mental health-related drug utilization among older adults: prevalence, trends, and costsMuhammad Mamdani, Mark Rapoport, Kenneth I Shulman, et al.
Psychoneuroendocrinology|September 23, 2022
Depression interacts with allostatic load to predict cognitive decline in middle ageGeorge Perlman, Hugo Cogo-Moreira, Che-Yuan Wu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 3, 2020
The Role of the Medical Expert in the Retrospective Assessment of Testamentary CapacityKenneth Shulman, Nathan Herrmann, Hayley Peglar, et al.
Current Topics in Behavioral Neurosciences|May 26, 2016
Evidence for Inflammation-Associated DepressionCelina S Liu, Alexander Adibfar, Nathan Herrmann, et al.
Drugs - Real World Outcomes|July 12, 2016
Persistence of Antipsychotic Treatment in Elderly Dementia Patients: A Retrospective, Population-Based Cohort StudyGavin Mast, Kimberly Fernandes, Mina Tadrous, et al.
Canadian Geriatrics Journal : CGJ|July 7, 2018
Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot StudySarah A Chau, Nathan Herrmann, Jonathan Chung, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2016
Distraction adds to the cognitive burden in multiple sclerosisViral P Patel, Aaron Zambrana, Lisa As Walker, et al.
CNS Drugs|November 5, 2003
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approachGrace Wu, Krista L Lanctôt, Nathan Herrmann, et al.
Neurobiology of Aging|February 7, 2012
Effects of ω-3 fatty acids on cognitive performance: a meta-analysisGraham Mazereeuw, Krista L Lanctôt, Sarah A Chau, et al.
Pageof 47

Showing results (101-110 of 470) with videos related to

Sort By:
Pageof 47
Neuroscience and Biobehavioral Reviews|February 2, 2013
Interleukin-17 in post-stroke neurodegenerationWalter Swardfager, Daniel A Winer, Nathan Herrmann, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 15, 2005
Mental health-related drug utilization among older adults: prevalence, trends, and costsMuhammad Mamdani, Mark Rapoport, Kenneth I Shulman, et al.
Psychoneuroendocrinology|September 23, 2022
Depression interacts with allostatic load to predict cognitive decline in middle ageGeorge Perlman, Hugo Cogo-Moreira, Che-Yuan Wu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 3, 2020
The Role of the Medical Expert in the Retrospective Assessment of Testamentary CapacityKenneth Shulman, Nathan Herrmann, Hayley Peglar, et al.
Current Topics in Behavioral Neurosciences|May 26, 2016
Evidence for Inflammation-Associated DepressionCelina S Liu, Alexander Adibfar, Nathan Herrmann, et al.
Drugs - Real World Outcomes|July 12, 2016
Persistence of Antipsychotic Treatment in Elderly Dementia Patients: A Retrospective, Population-Based Cohort StudyGavin Mast, Kimberly Fernandes, Mina Tadrous, et al.
Canadian Geriatrics Journal : CGJ|July 7, 2018
Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot StudySarah A Chau, Nathan Herrmann, Jonathan Chung, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2016
Distraction adds to the cognitive burden in multiple sclerosisViral P Patel, Aaron Zambrana, Lisa As Walker, et al.
CNS Drugs|November 5, 2003
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approachGrace Wu, Krista L Lanctôt, Nathan Herrmann, et al.
Neurobiology of Aging|February 7, 2012
Effects of ω-3 fatty acids on cognitive performance: a meta-analysisGraham Mazereeuw, Krista L Lanctôt, Sarah A Chau, et al.
Pageof 47